200,000+ products from a single source!
sales@angenechem.com
Home > Fluorides > 719272-75-0
719272-75-0 | 3-(4-Fluorophenyl);-5-(4-(4-methyl-5-(2-(trifluoromethyl);phenyl);-4H-1,2,4-triazol-3-yl);bicyclo[2.2.2]octan-1-yl);-1,2,4-oxadiazole
CAS No: 719272-75-0 Catalog No: AG005EWX MDL No:MFCD13152290
Product Description
Catalog Number:
AG005EWX
Chemical Name:
3-(4-Fluorophenyl);-5-(4-(4-methyl-5-(2-(trifluoromethyl);phenyl);-4H-1,2,4-triazol-3-yl);bicyclo[2.2.2]octan-1-yl);-1,2,4-oxadiazole
CAS Number:
719272-75-0
Molecular Formula:
C26H23F4N5O
Molecular Weight:
497.4873
MDL Number:
MFCD13152290
IUPAC Name:
3-(4-fluorophenyl)-5-[4-[4-methyl-5-[2-(trifluoromethyl)phenyl]-1,2,4-triazol-3-yl]-1-bicyclo[2.2.2]octanyl]-1,2,4-oxadiazole
InChI:
InChI=1S/C26H23F4N5O/c1-35-21(18-4-2-3-5-19(18)26(28,29)30)32-33-22(35)24-10-13-25(14-11-24,15-12-24)23-31-20(34-36-23)16-6-8-17(27)9-7-16/h2-9H,10-15H2,1H3
InChI Key:
FRKIPPLTMSQJLF-UHFFFAOYSA-N
SMILES:
Fc1ccc(cc1)c1noc(n1)C12CCC(CC1)(CC2)c1nnc(n1C)c1ccccc1C(F)(F)F
Properties
Complexity:
766
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
497.184g/mol
Formal Charge:
0
Heavy Atom Count:
36
Hydrogen Bond Acceptor Count:
9
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
497.498g/mol
Monoisotopic Mass:
497.184g/mol
Rotatable Bond Count:
4
Topological Polar Surface Area:
69.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
5.5
Literature
| Title | Journal |
|---|---|
| Further studies with the 2-amino-1,3-thiazol-4(5H)-one class of 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: reducing pregnane X receptor activity and exploring activity in a monkey pharmacodynamic model. | Journal of medicinal chemistry 20081225 |
| Blockade of glucocorticoid excess at the tissue level: inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 as a therapy for type 2 diabetes. | Journal of medicinal chemistry 20080828 |
| Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11beta-HSD1: novel therapeutic agents for the treatment of metabolic syndrome. | Bioorganic & medicinal chemistry letters 20051201 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.